These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
927 related articles for article (PubMed ID: 19305378)
21. Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome. Skagen C; Einstein M; Lucey MR; Said A J Clin Gastroenterol; 2009 Aug; 43(7):680-5. PubMed ID: 19238094 [TBL] [Abstract][Full Text] [Related]
23. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Moreau R; Lebrec D Hepatology; 2006 Mar; 43(3):385-94. PubMed ID: 16496352 [TBL] [Abstract][Full Text] [Related]
27. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy. Arroyo V Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402 [TBL] [Abstract][Full Text] [Related]
28. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment. Wong F; Raina N; Richardson R Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033 [TBL] [Abstract][Full Text] [Related]
29. New insights into the management of hepato-renal syndrome. Hasper D; Jörres A Liver Int; 2011 Sep; 31 Suppl 3():27-30. PubMed ID: 21824281 [TBL] [Abstract][Full Text] [Related]
30. Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies. Meltzer J; Brentjens TE Curr Opin Anaesthesiol; 2010 Apr; 23(2):139-44. PubMed ID: 20124895 [TBL] [Abstract][Full Text] [Related]
31. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment]. Torre A; Terra C; Guevara M; Ginès P Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529 [No Abstract] [Full Text] [Related]
32. The hepatorenal syndrome. Munoz SJ Med Clin North Am; 2008 Jul; 92(4):813-37, viii-ix. PubMed ID: 18570944 [TBL] [Abstract][Full Text] [Related]
33. [Therapy of hepatorenal syndrome]. Walter E Praxis (Bern 1994); 1997 Jan; 86(4):102-3. PubMed ID: 9064719 [TBL] [Abstract][Full Text] [Related]
34. Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis. Angeli P; Merkel C J Hepatol; 2008; 48 Suppl 1():S93-103. PubMed ID: 18304678 [TBL] [Abstract][Full Text] [Related]
35. Hepatorenal syndrome: a dreaded complication of end-stage liver disease. Cárdenas A Am J Gastroenterol; 2005 Feb; 100(2):460-7. PubMed ID: 15667508 [TBL] [Abstract][Full Text] [Related]